FIAP, May 11-Zhifei Biology announced that the therapeutic BCG vaccine independently developed by a wholly owned subsidiary, Zhifeilong Koma, was approved by the State Drug Administration of the State Drug Administration for clinical trial approval, agreeing to carry out clinical trials of the drug.